Von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhu, Ximin ^a   Cao, Yongliang ^a   Wei, Lixiang ^a   Cai, Ping ^a   Xu, Haochen ^a   Luo, Haiyu ^a   Bai, Xiaofei ^a   Lu, Lu ^a   Liu, Jian Ren ^b   Fan, Wenying ^a   Zhao, Bing Qiao ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; GELATINASE B; ICAM1 PROTEIN, MOUSE; INTERCELLULAR ADHESION MOLECULE 1; MMP9 PROTEIN, MOUSE; VON WILLEBRAND FACTOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMORRHAGE; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS;

ANIMALS; ANTIBODIES, BLOCKING; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; PROGNOSIS; VON WILLEBRAND FACTOR;

EID: 84992549265     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep35901     Document Type: Article

References (50)

1. Vischer, U. M. & de Moerloose, P. von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease. Crit. Rev. Oncol. Hematol. 30, 93-109 (1999).
2. Nieswandt, B. & Stoll, G. The smaller, the better: VWF in stroke. Blood. 115, 1477-1478 (2010).
3. Ruggeri, Z. M. Von Willebrand factor, platelets and endothelial cell interactions. J. Thromb. Haemost. 1, 1335-1342 (2003).
4. Chauhan, A. K. et al. ADAMTS13: a new link between thrombosis and inflammation. J. Exp. Med. 205, 2065-2074 (2008).
5. Gandhi, C., Khan, M. M., Lentz, S. R. & Chauhan, A. K. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. Blood. 119, 2385-2391 (2012).
6. Zhao, B. Q. et al. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood. 114, 3329-3334 (2009).
7. Petri, B. et al. von Willebrand factor promotes leukocyte extravasation. Blood. 116, 4712-4719 (2010).
8. Keep, R. F., Hua, Y. & Xi, G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet. Neurol. 11, 720-731 (2012).
9. Ziai, W. C. Hematology and inflammatory signaling of intracerebral hemorrhage. Stroke. 44, S74-S78 (2013).
10. Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 468, 562-566 (2010).
11. Winkler, E. A., Bell, R. D. & Zlokovic, B. V. Central nervous system pericytes in health and disease. Nat Neurosci. 14, 1398-1405 (2011).
12. Hall, C. N. et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 508, 55-60 (2014).
13. Imai, T. et al. Nrf2 activator ameliorates hemorrhagic transformation in focal cerebral ischemia under warfarin anticoagulation. Neurobiol. Dis. 89, 136-146 (2016).
14. Fernandez-Klett, F. et al. Early loss of pericytes and perivascular stromal cell-induced scar formation after stroke. J. Cereb. Blood. Flow. Metab. 33, 428-439 (2013).
15. Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 485, 512-516 (2012).
16. Suidan, G. L. et al. Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice. Arterioscler. Thromb. Vasc. Biol. 33, 2112-2120 (2013).
17. Brill, A. et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 117, 1400-1407 (2011).
18. Hillgruber, C. et al. Blocking von Willebrand factor for treatment of cutaneous inflammation. J. Invest. Dermatol. 134, 77-86 (2014).
19. Noubade, R. et al. von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis. AM. J. Pathol. 173, 892-900 (2008).
20. Zhao, X., Zhang, Y., Strong, R., Grotta, J. C. & Aronowski, J. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J. Cereb. Blood. Flow. Metab. 26, 811-820 (2006).
21. Rosenberg, G. A. & Navratil, M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology. 48, 921-926 (1997).
22. del Zoppo, G. J. Acute anti-inflammatory approaches to ischemic stroke. Ann. N. Y. Acad. Sci. 1207, 143-148 (2010).
23. Fan, X., Lo, E. H. & Wang, X. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats. Stroke. 44, 745-752 (2013).
24. Kleinschnitz, C. et al. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 115, 2323-2330 (2007).
25. Xi, G., Strahle, J., Hua, Y. & Keep, R. F. Progress in translational research on intracerebral hemorrhage: is there an end in sight? Prog. Neurobiol. 115, 45-63 (2014).
26. Bernardo, A. et al. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J. Thromb. Haemost. 3, 562-570 (2005).
27. Andre, P. et al. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood. 96, 3322-3328 (2000).
28. Dole, V. S., Bergmeier, W., Mitchell, H. A., Eichenberger, S. C. & Wagner, D. D. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood. 106, 2334-2339 (2005).
29. Bath, P. M., Blann, A., Smith, N. & Butterworth, R. J. Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome. Platelets. 9, 155-159 (1998).
30. Vergouwen, M. D. et al. Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J. Cereb. Blood. Flow. Metab. 29, 1734-1741 (2009).
31. Gandhi, C., Motto, D. G., Jensen, M., Lentz, S. R. & Chauhan, A. K. ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice. Blood. 120, 5224-5230 (2012).
32. Zhang, L. et al. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation. 112, 3486-3494 (2005).
33. Ma, Q. et al. Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice. J. Cereb. Blood. Flow. Metab. 31, 881-893 (2011).
34. Pfefferkorn, T. & Rosenberg, G. A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke. 34, 2025-2030 (2003).
35. Amenta, P. S., Jallo, J. I., Tuma, R. F., Hooper, D. C. & Elliott, M. B. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury. J. Neuroinflammation. 11, 191 (2014).
36. Claus, R. A., Bockmeyer, C. L., Sossdorf, M. & Lösche, W. The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure? Curr. Mol. Med. 10, 236-248 (2010).
37. Tsubokawa, T. et al. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke. 37, 1888-1894 (2006).
38. del Zoppo, G. J. Acute anti-inflammatory approaches to ischemic stroke. Ann. N. Y. Acad. Sci. 1207, 143-148 (2010).
39. Yang, Y. & Rosenberg, G. A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 42, 3323-3328 (2011).
40. Rynkowski, M. A. et al. A mouse model of intracerebral hemorrhage using autologous blood infusion. Nat. Protoc. 3, 122-128 (2008).
41. Glascock, J. J. et al. Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice. J. Vis. Exp. 56, e2968 (2011).
42. Snyder, E. Y., Taylor, R. M. & Wolfe, J. H. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature. 374, 367-370 (1995).
43. Passini, M. A. & Wolfe, J. H. Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector. J. Virol. 24, 12382-12392 (2001).
44. Yepes, M. et al. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112, 1533-1540 (2003).
45. Su, E. J. et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat. Med. 14, 731-737 (2008).
46. Lenting, P. J. et al. An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation. J. Biol. Chem. 279, 12102-12109 (2004).
47. Cai, P. et al. Recombinant ADAMTS 13 Attenuates Brain Injury After Intracerebral Hemorrhage. Stroke. 46, 2647-2653 (2015).
48. Fan, W. et al. Caspase-3 modulates regenerative response after stroke. Stem cells 32, 473-486 (2014).
49. Wang, L. et al. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice. Ann. Neurol. 73, 189-198 (2013).
50. Zhao, B. Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441-445 (2006).